Results 101 to 110 of about 2,543,947 (256)

Urinary and reproductive tract infection symptoms and menstrual hygiene practices in refugee camps in Jordan: A cross-sectional study

Women's Health
Background: Urinary tract infections and reproductive tract infections pose significant health risks, particularly among women living in challenging conditions.
Joud Al Karmi, Mohammad Ali Alshrouf, Tala A Haddad, Abdulrahman E Alhanbali, Neven Amer Raiq, Hadeel Ghanem, Omar Bassam Ibrahim, Tala Khamis, Nadia Muhaidat   +8 more
doaj   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Prevalence and Pattern of Microbial Resistance of Urinary Pathogens Resistant to Quinolones [PDF]

Beyhagh
Background and Aim: Urinary tract infection is an infection in any part of the urinary system including kidneys, ureters, bladder and urethra. Most infections involve the lower urinary tract such as the bladder and urethra. Women are more susceptible to
Zeinab Siami
doaj  

Efficacy and safety of empagliflozin for treating neutropenia and neutrophil dysfunction in paediatric patients with glycogen storage disease type Ib: A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims Glycogen storage disease type Ib (GSD‐Ib) is a rare genetic disorder causing neutropenia and neutrophil dysfunction in children. G‐CSF has been the primary treatment, but emerging data support the potential of empagliflozin, an SGLT2 inhibitor, as a promising investigational option.
Elizabeth Iwasyk, Ryan Jin, Fabio Tuzzolino, Giusy Ranucci, Donatella Madonia, Alessio Provenzani   +5 more
wiley   +1 more source

Immunology of urinary tract infections

, 2020
The urinary tract is constantly exposed to different microorganisms that colonize the gastrointestinal tract and the urinary tract is normally well prepared to resist infections by these microorganisms. This resistance to infection is mainly accomplished
Ortega Martell, JA
core   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

British Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay, Amandine Manon, Hunter Stephens, S. Y. Amy Cheung, Bart de Keizer, Erik T. te Beek   +5 more
wiley   +1 more source

Infants with urinary tract infection - renal damage and risk factors [PDF]

, 2010
Background Identification of infants with urinary tract infection (UTI) who are at risk of renal scarring is an important clinical challenge with considerable economic consequences.
Preda, Iulian
core   +1 more source

14. URINARY TRACT INFECTION (UTI)

, 2014
14 URINARY TRACT INFECTION ...
HAERANI RASYID, HAERANI RASYID
core  

Nosocomial Urinary Tract Infection

, 2009
Nosocomial urinary tract infection, a common complication in surgical patients, is primarily related to the use of indwelling urinary catheters. Discontinuation of catheter usage within 2 days, whenever possible, is the cornerstone to avoiding these ...
Ksycki, Michael F, Namias, Nicholas
core   +1 more source

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden, Miriam G. Mooij, Matthijs de Hoog, Saskia N. de Wildt   +3 more
wiley   +1 more source